Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.
This growth is fueled by the escalating demand for biologics and biosimilars, continued innovation in cell line engineering, and increasing applications in gene therapy, monoclonal antibody production ...
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback